4PM Ventures

🌟 Welcome to 4PM Ventures! 🚀 We are excited to share an important moment in our history. As you know, we were previously known as EXPANSE Capital, and our main focus was assisting Health Tech startups in relocating to the EU and promoting them in the European market. We operated at the intersection of medical innovation and acceleration, and our journey was filled with unique challenges and inspiring success stories. However, as we grew and evolved, and the EU market situation changed, we realized that our name and business model needed to evolve as well. We strive for growth and the use of advanced international expertise, and our old identity no longer fully aligned with these goals. Therefore, we are proud to introduce 4PM Ventures – a new era in our history. 4PM Ventures is not just a new name; it represents our new approach to supporting breakthrough Health Tech startups and developing an ecosystem that brings together founders, new technologies, clinics, science, and investors. We will continue our journey as a venture builder and accelerator, transforming healthcare to be higher quality and more accessible for everyone. What is 4PM: 4PM: a modern concept of medical development 4PM: an advanced concept of project management 4PM: Patient management 4PM: Platform management 4:PM: The time to focus on your startup We invite you to join us in this new stage of our development, and we look forward to meeting those in the European Health Tech industry whom we have not yet met. Let’s tackle the challenges facing healthcare together! We will be delighted to share our news with you in our new capacity. Subscribe to our page to stay connected!

Europe Awaits: Fundraising and Scaling Without Borders Startups in the healthcare and technology sectors often face challenges related to securing investments and entering new markets. The European market, with its advanced ecosystem, strict regulations, and high level of competition, requires a tailored approach. Why is this important? Europe offers a platform for scaling and attracting strategic partners. However, success here hinges on a well-crafted fundraising strategy. Investors expect startups to demonstrate scalability, a deep understanding of market trends, the ability to integrate innovations into existing infrastructure, regulatory compliance, and a clear roadmap with realistic timelines for market entry and sales growth. Steps to Take: 1️⃣ Market Analysis and Segmentation – Understand local needs and trends within each country. 2️⃣ Building the Right Team – Engage experienced industry advisors and organize pilot projects in well-known clinics across EU countries. 3️⃣ Finding the Right Investor – European funds favor platform-based solutions and projects with strong social impact. For startups focusing on healthcare transformation, it’s crucial to seek investors with industry expertise who understand your product and its value. 4️⃣ Defining the Business Model – In healthcare, identifying the payer can be complex (patient, family members, doctor, clinic, insurance company, pharmaceutical or medical manufacturer). A thorough stakeholder analysis is essential, distinguishing healthcare projects from other deep tech startups. 5️⃣ Regulatory Compliance – Meet European regulatory requirements, including ISO, GDPR, CE marking, and understand the differences from FDA regulations. Learn more about how we prepare startups for pilot projects – the link is in the first comment! At 4PM Ventures, we already see success in startups that collaborate with accelerators and venture builders. This approach helps startups quickly adapt to market requirements, find partners, and attract early users. If your startup plans to enter international markets or is facing barriers such as launching pilots with clinics, regulatory challenges, or funding issues, reach out to us! Describe your obstacles and goals, and let’s explore how we can help overcome them. Share your experience in the comments, and we’ll provide further insights on preparing your project for the European market. #TechStartups #HealthcareInnovation #ScalingUp #FundraisingStrategy #EuropeExpansion #StartupSuccess #VentureCapital #BusinessDevelopment #MarketEntry #RegulatoryCompliance #StartupGrowth #4PMVentures #PilotProjects #StrategicPartnerships #InnovationEcosystem

We continue our Friday series where we review and announce studies that we find interesting and that we recommend investors and founders pay attention to. Today, we will be providing an overview of the report “A comprehensive guide to market access in Germany” published by EIT Health. Germany is emerging as a pivotal hub for HealthTech and digital health innovations, offering significant opportunities for startups and established companies alike. With a population of approximately 84.7 million, the country faces evolving healthcare challenges, particularly due to its ageing demographic, which is projected to increase the demand for long-term care services dramatically. The German healthcare system is characterized by a robust regulatory framework that ensures high standards of safety and efficacy for medical devices and digital health solutions. Key regulatory bodies, including the Federal Institute for Drugs and Medical Devices (BfArM) and the Federal Joint Committee (G-BA), play essential roles in overseeing market access and reimbursement decisions. Staying informed about the guidelines set forth by these authorities is crucial for any entity seeking to navigate this landscape. In 2022, Germany's healthcare expenditure reached approximately €498.1 billion, highlighting the country's commitment to delivering high-quality healthcare services. The MedTech sector is anticipated to grow to around €32 billion by 2024, while the digital health market is projected to reach €4.5 billion, driven by increasing investment in digital transformation and innovative health solutions. Emerging trends within the sector, such as digital transformation, assistive technologies, and mental health tech, underscore the potential for innovation. The growing focus on preventive care further emphasizes the need for solutions that can enhance patient outcomes and streamline healthcare delivery. Furthermore, engaging with support stakeholders, including patient advocacy groups and local development agencies, can provide valuable insights and foster collaboration within the healthcare ecosystem. By leveraging these resources and understanding the intricacies of the regulatory environment, companies can effectively position themselves to thrive in this dynamic market. As Germany leads the way in HealthTech and digital health, it offers a great opportunity for new solutions that meet the changing needs of patients and healthcare providers. Our Venture Builder is looking for projects in the digital health market and is ready to help founders develop them. If you have such a project, please send your investment deck to us hello@4pmventures.com

We continue our Friday series where we review and announce studies that we find interesting and that we recommend investors and founders pay attention to. Today, we will be providing an overview of the report “Digital Mental Health Technologies” published by Leavitt Partners. As the demand for digital mental health technologies continues to rise, understanding the regulatory framework surrounding these tools is essential. These are the factors impacting the market: Regulatory Limitations: Current federal authorities, including the FDA, often fall short in addressing the rapid evolution of digital technologies. Many DMHTs, particularly those employing artificial intelligence, require frequent updates that existing regulations struggle to accommodate. While some DMHTs are classified as medical devices and thus subject to FDA oversight, a significant number escape regulation, raising concerns about consumer safety and efficacy. Payment and Reimbursement Challenges: The relationship between FDA approval and reimbursement pathways remains complex. Many DMHTs serve multiple functions, complicating their classification and subsequent payment models. Recent efforts by CMS to introduce billing codes for DMHT services mark progress, yet many stakeholders express concerns that the narrow scope of prescription requirements may limit access to these vital tools. Data Privacy and Security Concerns: The privacy of sensitive health information is a critical issue. While DMHTs controlled by covered entities are subject to HIPAA, consumer-facing applications often fall outside these protections, leading to confusion about applicable privacy regulations. Ensuring clear guidance for consumers and providers is essential for building trust in these technologies. Addressing Health Disparities: DMHTs have the potential to bridge gaps in mental health and substance use disorder care, particularly for underserved populations. Vendors are increasingly focused on designing technologies that address disparities in access, including providing culturally relevant content and improving representation in clinical trials. However, barriers such as access to technology and funding for smaller vendors could hinder these efforts. The landscape of DMHT is evolving rapidly, and there is a pressing need for coordinated regulatory approaches that foster innovation while ensuring safety and efficacy. Our Venture Builder is looking for projects in the mental health market and is ready to help founders develop them. If you have such a project, please send your investment deck to us hello@4pmventures.com

We continue our Friday series where we review and announce studies that we find interesting and that we recommend investors and founders pay attention to. Today we will overview the report “Digital Health Trends 2024” prepared by IQVIA Institute. The digital health landscape is experiencing a remarkable transformation, with a variety of trends reshaping the way patients and healthcare providers interact. With the rise of digital health solutions, patients are increasingly taking control of their health journeys, supported by innovative tools that make monitoring and managing their conditions more accessible than ever. The growing popularity of digital assessment tools highlights a strong consumer demand for accessible and user-friendly health solutions. However, despite this surge in digital health engagement, challenges remain, particularly in the sphere of reimbursement. In the United States, only 27% of payers have approved pharmacy-dispensed digital therapeutics, which means that a staggering 91% of prescriptions are currently paid for out-of-pocket. This situation underscores the urgent need for improved reimbursement models to enhance accessibility and encourage wider adoption of these innovative tools. In contrast, Germany is witnessing a more favorable environment for digital therapeutics, thanks to a centralized system known as the DiGA directory that facilitates reimbursement. This has resulted in increased prescription volumes for digital solutions, especially for chronic conditions like pain and obesity. Such regulatory support demonstrates the potential benefits of integrating technology into healthcare. Another significant trend is the expansion of billing codes introduced by the Centers for Medicare & Medicaid Services (CMS), which facilitate reimbursement for digital health services, including remote monitoring and therapeutic digital care. This initiative is likely to encourage more healthcare providers to incorporate digital solutions into their practice, further enhancing patient engagement and care outcomes. The rise of remote monitoring also reflects the increasing acceptance of technology in patient care. As claims for remote physiological and therapeutic monitoring grow, we can anticipate improved patient engagement and better health management. As technology keeps advancing, it's important to focus on smoothly bringing digital health solutions into everyday healthcare. This will help make it easier for patients to access these tools and show how they can improve health outcomes. Our Venture Builder is looking for projects in digital health and is ready to help founders develop them. If you have such a project, please send your investment deck to us hello@4pmventures.com

News Baltic Healthtech innovation ecosystem See, study, add information about yourself to our Map of Baltic Healthtech Ecosystem: https://lnkd.in/dsphJ8pM #vc; #Baltichealthtechecosystem; #healthtech; #balticvc; #map

These are useful insights about the trends that are going to reshape the sphere of digital health.

We continue our Friday series where we review and announce studies that we find interesting and that we recommend investors and founders pay attention to. Today we will overview the report “State of Health Tech 2024” by Bessemer Venture Partners. The health tech market is undergoing a transformative phase, with several key trends shaping the future of healthcare delivery: Payer Administration Insourcing: As more healthcare organizations start using artificial intelligence (AI), we expect to see new companies focusing on improving workflows within payer organizations and third-party administrators (TPAs). This trend is driven by the rising costs of health insurance premiums, creating a demand for innovative solutions that help control costs and improve service quality by using AI technologies. Pharmacy Transparency: The complicated nature of prescription drug distribution has received a lot of attention, leading to efforts to make drug pricing clearer. Companies that can develop effective tools for managing rebates and analyzing drug costs are in a good position to meet the growing demand for transparency in the pharmaceutical pricing system. AI-Assisted Clinical Services: Instead of replacing healthcare providers, AI is set to enhance their work, improving the overall quality of patient care. Key opportunities in this field include assessing patient risk, managing triage, and tracking symptoms. These tools can help healthcare providers use their resources more effectively and prioritize patient needs better. Value-Based Care Systems: Technology, data integration, and AI will be essential in managing value-based contracts and improving patient outcomes, even with the challenges posed by different data sources and programs. As we look ahead to 2025, the integration of AI and emerging technologies offers a promising path for innovation in healthcare delivery. The focus on personalized care, seamless data sharing, and value-based healthcare will lead to major improvements in how healthcare is delivered. This will ultimately result in better patient outcomes and higher satisfaction among patients. Our Venture Builder is looking for projects in digital health and is ready to help founders develop them. If you have such a project, please send your investment deck to us hello@4pmventures.com

News from members of the Latvian Healthtech Ecosystem. Become a https://lnkd.in/erNt3TpE survey participant and find your place on the map https://lnkd.in/dsphJ8pM #vc; #health; #healthtech